Achieving the rigorous laboratory standard broadens access for providers and patients in New York; applies to use of Haystack ...
The FDA's Breakthrough Devices Program accelerates access to promising medical devices for serious conditions, ensuring safety and effectiveness through a rigorous review process. Haystack MRD test ...
GlobalData on MSN
Quest Diagnostics’ Haystack MRD test secures NYSDOH approval
The clearance gives New York clinicians access to the Haystack MRD assay, which detects residual or recurring solid tumour ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results